- Home
- GEVO vs CRMD Comparison
GEVO vs CRMD Comparison
Compare GEVO & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- CRMD
- Stock Information
- Founded
- GEVO 2005
- CRMD 2006
- Country
- GEVO United States
- CRMD United States
- Employees
- GEVO N/A
- CRMD N/A
- Industry
- GEVO Major Chemicals
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- CRMD Health Care
- Exchange
- GEVO Nasdaq
- CRMD Nasdaq
- Market Cap
- GEVO 749.5M
- CRMD 626.8M
- IPO Year
- GEVO 2011
- CRMD 2010
- Fundamental
- Price
- GEVO $1.43
- CRMD $10.33
- Analyst Decision
- GEVO Strong Buy
- CRMD Strong Buy
- Analyst Count
- GEVO 3
- CRMD 5
- Target Price
- GEVO $6.48
- CRMD $15.20
- AVG Volume (30 Days)
- GEVO 9.3M
- CRMD 1.7M
- Earning Date
- GEVO 11-07-2024
- CRMD 10-30-2024
- Dividend Yield
- GEVO N/A
- CRMD N/A
- EPS Growth
- GEVO N/A
- CRMD N/A
- EPS
- GEVO N/A
- CRMD N/A
- Revenue
- GEVO $15,589,000.00
- CRMD $12,262,234.00
- Revenue This Year
- GEVO $18.65
- CRMD N/A
- Revenue Next Year
- GEVO $56.15
- CRMD $277.75
- P/E Ratio
- GEVO N/A
- CRMD N/A
- Revenue Growth
- GEVO 16.59
- CRMD 41184.20
- 52 Week Low
- GEVO $0.48
- CRMD $2.89
- 52 Week High
- GEVO $3.39
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- GEVO 36.21
- CRMD 47.62
- Support Level
- GEVO $1.41
- CRMD $11.27
- Resistance Level
- GEVO $1.72
- CRMD $12.40
- Average True Range (ATR)
- GEVO 0.23
- CRMD 0.89
- MACD
- GEVO -0.15
- CRMD -0.17
- Stochastic Oscillator
- GEVO 1.96
- CRMD 20.90
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.